Estimation of the Number of General Anesthesia Cases Based on a Series of Nationwide Surveys on Twitter during COVID-19 Pandemic in Japan: A Statistical AnalysisArticle Published on 2021-02-082022-10-30 Journal: Medicina [Category] COVID-19, MERS, [키워드] acute respiratory syndrome analyzed Anesthesia Care caused changes in conducted coronavirus Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) correlation coefficient COVID-19 estimation general anesthesia Japan Japanese material mathematical number pandemic of COVID-19 performed programming provided quadratic programming questionnaire Region reported SARS-CoV-2 Sery Seven Society spread to surgical survey Twitter was reduced were used [DOI] 10.3390/medicina57020153 PMC 바로가기 [Article Type] Article
Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests5가지 SARS-CoV-2 항체 검사의 임상 성능 및 유용성 비교Comparative Study Published on 2021-02-082022-09-10 Journal: PLoS ONE [Category] MERS, 진단, 치료기술, [키워드] both groups comparable COVID-19 antibody COVID-19 patients cut-off Elecsy Elecsys epidemiological studies examined FIVE group immunochromatography in both groups Infection Interpretation Japanese Roche SARS-CoV-2 antibody SARS-CoV-2 antibody test serum sample serum samples severe cases severity specificity two group two groups [DOI] 10.1371/journal.pone.0246536 PMC 바로가기 [Article Type] Comparative Study
Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19COVID-19 환자에서 favipiravir에 의해 유발된 담즙정체성 간 손상 의심Case Reports Published on 2021-02-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] SARS, 치료제, [키워드] addition Administered alcoholic hepatitis Antibiotics Antimicrobial therapy antiviral drug Bacterial bacterial pneumonia Bilirubin Cholestasic Complication Deterioration drug therapy elevated expected extracorporeal membrane oxygenation Favipiravir Hepatitis High dose Hyperuricemia impaired liver function interferon Japanese liver dysfunction Liver function Liver injury Lopinavir Lopinavir/ritonavir monitoring Patient patient with COVID-19 Pneumonia promoted Ritonavir SARS-CoV2 SARS-CoV2 infection Side effect Side effects subsequent Support Suspected teratogenicity therapeutic effect total bilirubin transaminase Treatment triggered veno-venous extracorporeal membrane oxygenation worsened [DOI] 10.1016/j.jiac.2020.12.021 PMC 바로가기 [Article Type] Case Reports
COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarctionObservational Study Published on 2021-02-012022-10-05 Journal: Open Heart [Category] 임상, [키워드] 95% CI Acute coronary syndrome Acute myocardial infarction analysed comparable Complication complications COVID-19 pandemic Epidemiology Government hospitalised In-hospital death incidence incidence rate Instructing Japanese less Mortality Myocardial infarction occurred outcome Patient Percutaneous coronary intervention proportion reduction in resulting retrospective cohort study significantly significantly higher Symptom was performed [DOI] 10.1136/openhrt-2020-001497 PMC 바로가기 [Article Type] Observational Study
Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia중증 코로나19 폐렴을 동반한 일본 ESRD 사례 2건의 성공적인 치료Case Reports Published on 2021-02-012022-09-11 Journal: CEN case reports [Category] MERS, SARS, 진단, 치료제, [키워드] acute respiratory distress acute respiratory distress syndrome acute respiratory distress syndrome (ARDS) Admission anti-cytokine anti-cytokine therapy ARDS Clinical course cohort study coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 pneumonia Diabetic diabetic nephropathy disease distress effective End-stage renal disease End-stage renal disease (ESRD) ESRD exhibited Hemodialysis high mortality rate ICU Immunoglobulin indicate infected with COVID-19 intensive care intensive care unit Intravenous immunoglobulin Intravenous immunoglobulin (IVIG) IVIG Japanese Maintenance hemodialysis mechanical ventilation nephropathy novel Novel coronavirus novel coronavirus disease Patient patients renal renal disease respiratory distress Respiratory distress syndrome Severe COVID-19 pneumonia syndrome Tocilizumab treated Treatment were infected with COVID-19 [DOI] 10.1007/s13730-020-00512-7 PMC 바로가기 [Article Type] Case Reports
A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically usefulLAMP법으로 검출된 혈청 SARS-CoV-2 RNA가 임상적으로 유용한 파비피라비르(아비간)로 성공적으로 치료된 코로나19 폐렴 1예Case Reports Published on 2021-02-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] SARS, 치료기술, 치료제, [키워드] Administered anti-inflammatory treatment antiviral therapy Avigan clinically coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pneumonia COVID-19 treatment Day discharged Favipiravir followed by isothermal amplification Japanese LAMP Loop-mediated isothermal amplification Loop-mediated isothermal amplification (LAMP) male mechanical ventilation nasopharynx Pneumonia RNA SARS-CoV-2 RNA serum Severe COVID-19 pneumonia the patient treat treated Treatment Viremia [DOI] 10.1016/j.jiac.2020.10.011 PMC 바로가기 [Article Type] Case Reports
Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19Article Published on 2021-01-282022-10-04 Journal: Scientific Reports [Category] 임상, 치료법, [키워드] algebraic Analysis Baricitinib Cellular signalling networks Clinical efficacy combinations coronavirus Coronavirus infection correlation COVID-19 Data mining databases drug drugs Effect evade explain Good immunology immunosuppressive agent JAK/STAT JAK/STAT pathway Japanese KEGG Kyoto mathematical measles methotrexate network Nipah virus phenotype Prednisolone R 2 reduction in respiratory syncytial virus rheumatoid arthritis rheumatology tested Tocilizumab Tofacitinib Treatment viral infection viral infections viral system virus West Nile Virus yellow [DOI] 10.1038/s41598-021-82139-x PMC 바로가기 [Article Type] Article
Increase in suicide following an initial decline during the COVID-19 pandemic in Japan Research Published on 2021-01-152022-10-05 Journal: Nature human behaviour [Category] 치료법, [키워드] adverse impact changed children complex coronavirus disease COVID-19 COVID-19 pandemic declined effective exacerbate female Government increase initial Japan Japanese Mortality pandemic psychological health public health reduced risk second wave sustained [DOI] 10.1038/s41562-020-01042-z [Article Type] Research
Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, JapanOriginal Research Article Published on 2021-01-142022-10-30 Journal: JMA Journal [Category] COVID-19, [키워드] activity acute respiratory syndrome analyzed antibody Antibody test Blood Clusters collected conducted coronavirus coronavirus 2 coronavirus disease COVID-19 cross-sectional electrochemiluminescence immunoassay enzyme Epidemiology FIVE Government hospital Hyogo immunoassay immunochromatographic Japan Japanese lifted Neutralizing activity neutralizing antibody pandemic Patient positive positive rate required respiratory risk SARS-CoV-2 SARS-COV-2 infection Seroprevalence survey tested the patient [DOI] 10.31662/jmaj.2020-0094 PMC 바로가기 [Article Type] Original Research Article
A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)Kampo 의약품을 사용한 COVID-19 예방에 대한 다기관, 무작위 대조 시험(RCT) 연구 프로토콜의 구조화된 요약(예방 연구에 의한 전염병에 대한 일본의 통합 관리: IMJEDI P1 연구)Letter Published on 2021-01-062022-08-31 Journal: Trials [Category] MERS, 임상, 치료제, [키워드] 1:1 administration age allergic Analysis appearance Arm ARMS assumed Asymptomatic balancing Blinding body temperature calculated capture cardiovascular disease Chain Reaction clinical clinical trials cloud condition Control control group cough COVID-19 diabetes disappearance dissemination doctor dosage dropout rate drug edema effective element Endpoint exclusion criteria failure Fever Final final analysis final analysis) Frequency group hands healthy history hospital Hospitalization hypertension hypokalaemia Hypothesis ICU Immunosuppressant immunosuppressants incidence of COVID-19 incidence rate incidence rates include inclusion criteria Infection infection rate Inflammation interim analysis interstitial pneumonia intervention group investigator Japan Japanese Kampo Kampo medicines liver dysfunction lung malaise management mechanical ventilation Medicine number numbness objective observation period oral administration oral administration) outcome package parallel-group participant Patient PCR PCR positive per day Period pharmaceutical Placebo placebo group Placebo tablets positive result power power of 80% pregnant Prevent Prophylactic prophylactic study protocol randomised Randomized Randomized controlled trial RCT receive recruited Registered Registration registry required Research respiratory respiratory diseases respiratory inflammation risk factor Risk factors Safety Sample size SARS-CoV-2 RNA secondary Secondary outcomes Shock Shortness of breath significantly skin rash sputum study drug study period Study protocol supplementary material Symptom Symptoms symptoms of COVID-19 Tablet Taking Taste the placebo group Trial Trial registration Two-arm university upper respiratory verification Viral viral infection Vital website [DOI] 10.1186/s13063-020-04939-2 PMC 바로가기 [Article Type] Letter